Atlas Trials

POETIC Plerixafor as a Chemosensitizing Agent for Relapsed Acute Leukemia and MDS in Pediatric Patients

Clinical trial NCT01319864 · COMPLETED

Trial details

NCT number
NCT01319864
Sponsor
Seattle Children's Hospital
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Relapsed/Refractory AMLRelapsed/Refractory ALLSecondary AML/MDSAcute Leukemia of Ambiguous LineageAMLALL
Start date
2011-03-01
Primary completion
2013-06-28
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.